98%
921
2 minutes
20
Background: We describe the requirements and physiological changes when running 10 consecutive marathons in 10 days at the same consistent pace by a female ultra-endurance athlete.
Methods: Sharon Gayter (SG) 54 yrs, 162.5 cm, 49.3 kg maximal oxygen uptake (VO max) 53 mL/kg/min. SG completed 42.195 km on a treadmill every day for 10 days. We measured heart rate (HR), Rating of Perceived Exertion (RPE), oxygen uptake (VO), weight, body composition, blood parameters, nutrition, and hydration.
Results: SG broke the previous record by ~2.5 h, with a cumulative completion time of 43 h 51 min 39 s. Over the 10 days, weight decreased from 51 kg to 48.4 kg, bodyfat mass from 9.1 kg to 7.2 kg (17.9% to 14.8%), and muscle mass from 23.2 kg to 22.8 kg. For all marathons combined, exercise intensity was ~60% VO max; VO 1.6 ± 0.1 L.min/32.3 ± 1.1 mL.kg.min, RER 0.8 ± 0, HR 143 ± 4 b.min. Energy expenditure (EE) was 2030 ± 82 kcal/marathon, total EE for 10 days (including BMR) was 33,056 kcal, daily energy intake (EI) 2036 ± 418 kcal (20,356 kcal total), resulting an energy deficit (ED) of 12,700 kcal.
Discussion: Performance and pacing were highly consistent across all 10 marathons without any substantial physiological decrements. Although overall EI did not match EE, leading to a significant ED, resulting in a 2.6 kg weight loss and decreases in bodyfat and skeletal muscle mass, this did not affect performance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621928 | PMC |
http://dx.doi.org/10.3390/ijerph182212066 | DOI Listing |
Neurobiol Dis
August 2025
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy. Electronic address:
Physical exercise (PE) improves clinical outcomes in individuals with Parkinson's disease (PD) through unclear mechanisms. Irisin, a neuroprotective protein released by myocytes during PE, may play a role, but in vivo data in PD are limited. We investigated plasma irisin in a unique PD population engaged in chronic, intense PE.
View Article and Find Full Text PDFInt J Sports Phys Ther
August 2025
Physical Therapy Universidade de São Paulo.
Background: Endurance athletes (EA) with lung disease and allergic inflammation have worse performance.
Purpose: To examine whether pharmacological treatment can reduce airway disorders such as exercise-induced bronchoconstriction (EIB) and allergic inflammatory response (AIR) in EA.
Study Design: Prospective, controlled clinical trial.
Biology (Basel)
July 2025
Applied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Marathon running exerts physical stress and may lead to transient immune dysregulation, increasing susceptibility to airway inflammation and exercise-induced bronchoconstriction (EIB). This study investigated systemic levels of antimicrobial peptides in athletes and their association with EIB. Serum concentrations of angiogenin, human beta-defensin 2 (hBD-2), major basic protein (MBP), S100A8, and S100A8/A9 were measured in 34 marathoners and 36 half-marathoners at baseline, immediately after a race, and seven days postrace using enzyme-linked immunosorbent assays and compared with 30 sedentary controls.
View Article and Find Full Text PDFDisaster Med Public Health Prep
July 2025
BIDMC Disaster Medicine Fellowship, Department of Emergency Medicine, https://ror.org/04drvxt59Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Objectives: As temperatures globally continue to rise, sporting events such as marathons will take place on warmer days, increasing the risk of exertional heat stroke (EHS).
Methods: The medical librarian developed and executed comprehensive searches in Ovid MEDLINE, Ovid Embase, CINAHL, SPORTDiscus, Scopus, and Web of Science Core Collection. Relevant keywords were selected.
Int J Mol Sci
June 2025
Department of Cardiac, Thoracic, and Vascular Sciences, University of Padova, 35122 Padua, Italy.
Ultramarathon running elicits a profound inflammatory response, characterized by significant increases in interleukin-6 (IL-6) and C-reactive protein (CRP), with comparatively modest changes in tumor necrosis factor-alpha (TNF-α). We reviewed approximately 80 field studies of ultramarathon events (distances >42.2 km) that measured IL-6, CRP, and TNF-α before and after races.
View Article and Find Full Text PDF